1996
DOI: 10.1097/00006123-199609000-00105
|View full text |Cite
|
Sign up to set email alerts
|

Intrathecal Morphine Pump as a Treatment Option in Chronic Pain of Nonmalignant Origin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
50
0

Year Published

2000
2000
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(57 citation statements)
references
References 0 publications
7
50
0
Order By: Relevance
“…It is indicated for pain reduction in stage 3 of the WHO step pattern during cancer therapy, and occasionally when benign diseases are diagnosed [7,8,11].…”
Section: Discussionmentioning
confidence: 99%
“…It is indicated for pain reduction in stage 3 of the WHO step pattern during cancer therapy, and occasionally when benign diseases are diagnosed [7,8,11].…”
Section: Discussionmentioning
confidence: 99%
“…[74][75][76] Other side effects mentioned were provocation of asthma, 86 insomnia, 86 dry mouth, 86 nightmares, 86 myoclonic jerk/ spasm, 86 dizziness, 76,86 loss of appetite, 86 diarrhea, 76 and headache. 76 Hardware complications were reported commonly.…”
Section: Complicationsmentioning
confidence: 99%
“…Furthermore, the value of epidural injections for the treatment of existing PHN has not been evaluated (van Wijck et al, 2010). Continuous infusions of analgesic agents (typically an opioid or local anesthetic) via an externalized intrathecal catheter or internalized intrathecal pump may also be used for the treatment of PHN, although no controlled trials examining the analgesic efficacy of these modalities are available (Angel et al, 1998;Nitescu et al, 1998). In extreme cases, refractory to all treatment options, other interventional strategies were described in the literature.…”
Section: Interventional Managementmentioning
confidence: 99%